Home › Zyoxel Announces The Performance Of Tests By Sanofi On The Power Of 3D Liver Culture Models For More Predictive And Insightful DMPK Studies
 

Keywords :   


Zyoxel Announces The Performance Of Tests By Sanofi On The Power Of 3D Liver Culture Models For More Predictive And Insightful DMPK Studies

2013-12-04 06:22:33| drugdiscoveryonline News Articles

Zyoxel, the world’s leading expert for advanced in vitro 3D liver models for drug discovery and drug testing, has announced preliminary results from a testing by Sanofi on Zyoxel’s LiverChip platform for drug metabolism and pharmacokinetic (DMPK) studies

Tags: power performance culture studies

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Delayed implementation of EID eartag rule requested
More »